Ross S Thomas Selected Research

Breast Neoplasms (Breast Cancer)

10/2015	APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.
12/2013	Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.
7/2011	Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.
6/2011	The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.
5/2009	CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.
4/2008	Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross S Thomas Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 10/2015 - 04/2008
3	Neoplasms (Cancer) 10/2015 - 06/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2015
1	Carcinogenesis 05/2009

Drug/Important Bio-Agent (IBA)

3	Estrogen ReceptorsIBA 10/2015 - 06/2011
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2013 - 05/2009
2	Tamoxifen FDA LinkGeneric 07/2011 - 04/2008
2	Estrogens (Estrogen)FDA Link 07/2011 - 06/2011
2	Estrogen Receptor alphaIBA 05/2009 - 04/2008
1	ChromatinIBA 10/2015
1	CytidineIBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 12/2013
1	Aromatase InhibitorsIBA 07/2011
1	Caseins (Casein)FDA Link 05/2009

Therapy/Procedure

3	Therapeutics 07/2011 - 04/2008